Related references
Note: Only part of the references are listed.Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling
Siyu Tan et al.
CANCER RESEARCH (2020)
Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC
Paul Giroud et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of cytokines in the regulation of NK cells in the tumor environment
Gordana M. Konjevic et al.
CYTOKINE (2019)
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector
Wenjuan Dong et al.
CANCER DISCOVERY (2019)
MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells
Marlies J. W. Peeters et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
Frank Vari et al.
BLOOD (2018)
Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction
Xin Li et al.
IMMUNITY (2018)
LAG-3 Inhibitory Receptor Expression Identifies Immunosuppressive Natural Regulatory Plasma Cells
Andreia C. Lino et al.
IMMUNITY (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
Nayoung Kim et al.
FRONTIERS IN IMMUNOLOGY (2018)
The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment
Jason B. Williams et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Targeting NK-cell checkpoints for cancer immunotherapy
Aura Muntasell et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Anjali Mishra et al.
CANCER DISCOVERY (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma
Liyun Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
MERTK as negative regulator of human T cell activation
Raquel Cabezon et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
Holbrook E. Kohrt et al.
BLOOD (2014)
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
Andrew Spencer et al.
BLOOD (2014)
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Magdalena Paolino et al.
NATURE (2014)
Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) Pathway Initiated by T Cell Antigen Receptor (TCRγδ) Activation Is Required to Overcome Inhibition by Ubiquitin Ligase Cbl-b during γδT Cell Cytotoxicity
Shanshan Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
Elizabeth R. Plimack et al.
ONCOLOGIST (2013)
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
Don M. Benson et al.
BLOOD (2012)
Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα
Noriko Sato et al.
BLOOD (2011)
NK cell development, homeostasis and function: parallels with CD8+ T cells
Joseph C. Sun et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Synergistic Signals for Natural Cytotoxicity Are Required to Overcome Inhibition by c-Cbl Ubiquitin Ligase
Hun Sik Kim et al.
IMMUNITY (2010)
IL-7 Enhances Survival of Human CD56bright NK Cells
Annie Michaud et al.
JOURNAL OF IMMUNOTHERAPY (2010)
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia
Akihiko Yokohama et al.
LEUKEMIA RESEARCH (2010)
Cbl-b regulates antigen-induced TCR down-regulation and IFN-γ production by effector CD8 T cells without affecting functional avidity
Mohammed Shamim et al.
JOURNAL OF IMMUNOLOGY (2007)
Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase casitas-B-lineage lymphoma protein-B
Guilin Qiao et al.
JOURNAL OF IMMUNOLOGY (2007)
Control of the B cell-intrinsic tolerance programs by ubiquitin ligases cbl and Cbl-b
Yasuyuki Kitaura et al.
IMMUNITY (2007)
Serial Killing of Tumor Cells by Human Natural Killer Cells - Enhancement by Therapeutic Antibodies
Rauf Bhat et al.
PLOS ONE (2007)
Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NTF-κB activation in dendritic cells
Pradip Sen et al.
BLOOD (2007)
IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation
Anthony R. French et al.
CYTOKINE (2006)
Twist mediates suppression of inflammation by type IIFNs and Axl
M. Nusrat Sharif et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
Anouk Caraux et al.
NATURE IMMUNOLOGY (2006)
Recruitment and activation of PLCγ1 in T cells:: a new insight into old domains
A Braiman et al.
EMBO JOURNAL (2006)
Phospholipase C-γ2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells
A Caraux et al.
BLOOD (2006)
The isoforms of phospholipase C-γ are differentially used by distinct human NK activating receptors
JL Upshaw et al.
JOURNAL OF IMMUNOLOGY (2005)
Negative regulation of FcεRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b
XJ Qu et al.
BLOOD (2004)
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
MS Jeon et al.
IMMUNITY (2004)
Natural killer cell signaling pathways
E Vivier et al.
SCIENCE (2004)
The Cbl family and other ubiquitin ligases: Destructive forces in control of antigen receptor signaling
L Duan et al.
IMMUNITY (2004)
The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models
E Kudlacz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Ubiquitin ligases and the immuneresponse
YC Liu
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b
WY Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells
M Strengell et al.
JOURNAL OF IMMUNOLOGY (2003)
Interleukin (IL)-15Ra-deficient natural killer cells survive in normal but not IL-15Ra-deficient mice
R Koka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity
MT Kasaian et al.
IMMUNITY (2002)
Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells
TA Fehniger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway
HH Gu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
MK Kennedy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Cbl-b regulates the CD28 dependence of T-cell activation
YPJ Chiang et al.
NATURE (2000)
Share Paper
